Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Arintra raises $25M in Series B funding led by Define Ventures. The Texas-based company is focused on leveraging generative AI for autonomous medical coding.
Peak Xv PartnersEndeavor VenturesYale New Haven VenturesSpider CapitalCounterpart VenturesTen13 CapitalY CombinatorDefine Ventures
Description
Arintra, headquartered in Texas, has successfully raised $25 million in a Series B funding round. The funding, led by Define Ventures, aims to enhance its autonomous medical coding platform. In addition to Define Ventures, several other prominent investors participated in the round. The company integrates generative AI to streamline clinical documentation and billing processes.
Company Information
Company
Arintra
Location
Austin, Texas, United States
About
Arintra provides the industry's leading GenAI-native autonomous coding platform, enabling health systems to get paid accurately and efficiently for the care they deliver, driving revenue assurance at scale. By combining cutting-edge AI with deep clinical expertise, Arintra autonomously codes charts with high accuracy, without human intervention. Unlike bolt-on tools, Arintra works directly within the EHR, ensuring seamless adoption with zero workflow changes or data integrity risk. Health systems use Arintra to unlock missed revenue due to coding gaps, documentation issues, and unchallenged denials - achieving 5%+ uplift in revenue, 12%+ reduction in A/R days, and 43%+ fewer denials.
Don't miss Arintra's next move
Get an email the moment Arintra raises, hires an exec, or expands, usually minutes after it happens.